Skip to main content

Table 1 Patient clinical characteristics

From: Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT

Patient (No) Age (y) Gender Primary tumor Biopsy site Tumor grade Ki67 value Indication of imagine Primary tumor resected Time between scans
(days)
1 55 M Throat Throat 1 2 Restage Yes 147
2 52 M Ileocecus Ileocecus 2 NA Restage Yes 2
3 63 M Rectum Rectum 2 3 Restage Yes 5
4 42 F Rectum Rectum 1 1 Stage No 2
5 24 F Pancreas Liver 3 40 Restage No 4
6 65 M Stomach Stomach 3 70 Stage No 4
7 57 M Pancreas Pancreas 1 1 Stage No 2
8 29 F Unknown liver 2 8 Stage No 1
9 48 F Rectum Rectum 2 NA Restage Yes 5
10 70 F Small intestine Small intestine 1 NA Restage Yes 8
11 67 M Pancreas Liver 2 NA Stage No 7
12 68 M Pancreas Liver 1  < 2 Stage No 5
13 59 M Unknown Liver 1 1 Stage No 1
14 60 F Pancreas Pancreas 1 1 Stage No 1
15 46 F Unknown Liver and Celiac 1 1 Stage No 279
16 56 F Pancreas Pancreas Insulinoma Stage No 1
17 57 M Unknown Neck 2 15 Stage No 1
18 50 M Pancreas Pancreas 2 10 Stage No 1
19 49 M Rectum Rectum 2 5 Restage Yes 2
20 47 F Paraganglioma Retroperitoneum NA NA Stage No 1
  1. NA not applicable